Cargando…
Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
BACKGROUND: The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer’s disease, whilst the ε2 allele confers protection. Previous studies report differential DNA methylation of APOE between ε4 and ε2 carriers, but associations with epigenome-wide methylatio...
Autores principales: | Walker, Rosie M., Vaher, Kadi, Bermingham, Mairead L., Morris, Stewart W., Bretherick, Andrew D., Zeng, Yanni, Rawlik, Konrad, Amador, Carmen, Campbell, Archie, Haley, Chris S., Hayward, Caroline, Porteous, David J., McIntosh, Andrew M., Marioni, Riccardo E., Evans, Kathryn L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784364/ https://www.ncbi.nlm.nih.gov/pubmed/33397400 http://dx.doi.org/10.1186/s13073-020-00808-4 |
Ejemplares similares
-
Epigenome‐wide analyses identify DNA methylation signatures of dementia risk
por: Walker, Rosie M., et al.
Publicado: (2020) -
Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022) -
DNA methylation in APOE: The relationship with Alzheimer's and with cardiovascular health
por: Mur, Jure, et al.
Publicado: (2020) -
Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration
por: Su, Wen-Hua, et al.
Publicado: (2017) -
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
por: Salvadó, Gemma, et al.
Publicado: (2021)